Medicare billing address
CMS Medicare provider billing file
30 Lacrue Ave Ste 101Glen Mills, PA 19342
CMS public data · NPI 1295909919
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Nehal S Gandhi, MD
Specialty
Credential
MD
NPI
1295909919
Primary source state
PA
Data retrieval date
July 27, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Nehal S Gandhi, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
30 Lacrue Ave Ste 101CMS Doctors & Clinicians file
201 2Nd AveCMS Doctors & Clinicians file
30 Lacrue AveIn the 2024 CMS provider billing file, this NPI had 1,034 Medicare beneficiaries and 965,257 total services. The average beneficiary age was 74, and the average HCC risk score was 1.2.
Total Medicare allowed amount
$10,575,072.57
Total Medicare payment amount
$8,429,953.28
Medicare beneficiaries
1,034
Total services
965,257
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
69%
CMS beneficiary-panel share
Osteoporosis
49%
CMS beneficiary-panel share
Anxiety
28%
CMS beneficiary-panel share
Mood disorders
28%
CMS beneficiary-panel share
Depression
25%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 507,600 | $4.52 |
| Injection, tocilizumab, 1 mg | 191,463 | $5.88 |
| Injection, golimumab, 1 mg, for intravenous use | 65,668 | $11.43 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 64,525 | $42.45 |
| Injection, romosozumab-aqqg, 1 mg | 36,750 | $10.80 |
| Injection, infliximab, excludes biosimilar, 10 mg | 35,890 | $30.96 |
| Injection, denosumab, 1 mg | 24,840 | $25.54 |
| Injection, secukinumab, intravenous, 1 mg | 13,625 | $17.22 |
| Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | 4,400 | $7.31 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 3,301 | $75.63 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1295909919. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 591 | 1,315 | $25,235.29 |
| 2 | Methotrexate | Methotrexate Sodium | 520 | 1,197.6 | $16,196.89 |
| 3 | Prednisone | Prednisone | 453 | 873 | $4,679.04 |
| 4 | Gabapentin | Gabapentin | 319 | 678.2 | $5,573.15 |
| 5 | Duloxetine Hcl | Duloxetine Hcl | 207 | 491 | $3,588.04 |
| 6 | Alendronate Sodium | Alendronate Sodium | 192 | 429.1 | $1,498.69 |
| 7 | Sulfasalazine Dr | Sulfasalazine | 169 | 377.1 | $10,089.35 |
| 8 | Leflunomide | Leflunomide | 143 | 347.3 | $8,765.80 |
| 9 | Folic Acid | Folic Acid | 96 | 243.3 | $1,548.54 |
| 10 | Meloxicam | Meloxicam | 92 | 147.3 | $263.18 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
1997
Group/practice field
Novacare Outpatient Rehabilitation East, Inc.
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.